세계의 망막정맥폐쇄증 치료 시장 보고서(2025년)

Retinal vein occlusion (RVO) treatment encompasses various approaches aimed at managing complications from blocked retinal blood vessels, focusing on reducing edema and preventing further vision loss.

The primary conditions treated for retinal vein occlusion are central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). CRVO involves a blockage of the central retinal vein, which can lead to vision impairment due to disrupted blood flow and potential retinal damage. Diagnosis often includes optical coherence tomography, fundoscopic examination, and fluorescein angiography. Treatments may involve anti-vascular endothelial growth factor (Anti-VEGF) agents, corticosteroids, and other options. These treatments are used by hospitals, clinics, research institutions, academic facilities, and similar entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The retinal vein occlusion treatment market research report is one of a series of new reports from The Business Research Company that provides retinal vein occlusion treatment market statistics, including retinal vein occlusion treatment industry global market size, regional shares, competitors with a retinal vein occlusion treatment market share, detailed retinal vein occlusion treatment market segments, market trends and opportunities, and any further data you may need to thrive in the retinal vein occlusion treatment industry. This retinal vein occlusion treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The retinal vein occlusion treatment market size has grown strongly in recent years. It will grow from $2.26 billion in 2024 to $2.42 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the adoption of combination therapies targeting multiple aspects of disease pathophysiology, the growing prevalence of diabetes and hypertension expanded access to healthcare services and specialized retinal care, clinical trials demonstrating the efficacy of new treatment modalities, and the development of anti-VEGF therapies.

The retinal vein occlusion treatment market size is expected to see strong growth in the next few years. It will grow to $3.16 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to cost-effectiveness and reimbursement policies, patient preferences for non-invasive treatments, increased healthcare spending globally, an increasing aging population, and the development of new drugs and therapies. Major trends in the forecast period include gene therapy advancements, nanotechnology for drug delivery, artificial intelligence (AI) in diagnostics, telemedicine and remote monitoring, and the development of patient-centric technologies.

The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced intravitreal therapies by inflating prices of microcatheters and thrombolytic agents developed in France and Belgium, resulting in prolonged vision recovery and higher retinal specialty costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the retinal vein occlusion treatment market is anticipated to increase due to the rising prevalence of eye conditions. Eye conditions encompass a range of disorders affecting vision, from minor irritations and infections to serious issues such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Factors contributing to the rise in eye conditions include an aging population and the growing rates of diabetes and hypertension. Retinal vein occlusion treatment focuses on restoring blood flow and reducing inflammation to prevent vision loss and manage related complications. For example, the Centers for Disease Control and Prevention reported in January 2024 that over 3.4 million Americans aged 40 and older were blind or visually impaired, with this number expected to double by 2030. This increase in eye conditions is driving growth in the retinal vein occlusion treatment market.

Key players in the retinal vein occlusion treatment market are developing innovative products such as interchangeable biosimilars to expand treatment options and improve patient access. An interchangeable biosimilar is a biologic drug closely similar to an existing reference biologic, used as an alternative for managing inflammation and fluid leakage. For instance, in May 2024, Biocon Biologics Limited, based in India, received approval from the US Food and Drug Administration for Yesafili (aflibercept-jbvf), an interchangeable biosimilar of EYLEA (aflibercept). This drug serves as a vascular endothelial growth factor (VEGF) inhibitor and is used to treat various ophthalmic conditions, including neovascular age-related macular degeneration (wet AMD), macular edema secondary to retinal vein occlusion (branch RVO or central RVO), diabetic macular edema (DME), and myopic choroidal neovascularization (myopic CNV).

In April 2022, Samsung Biologics Co. Ltd., a South Korea-based biotechnology company, acquired Samsung Bioepis for $2.3 billion. This acquisition is expected to boost Samsung Bioepis' sales, operating margins, and capabilities in biosimilar and novel drug development. Samsung Bioepis Co. Ltd. is a South Korean biopharmaceutical company that offers treatment for retinal vein occlusion with its biosimilar product BYOOVIZ (ranibizumab-nuna).

Major companies operating in the retinal vein occlusion treatment market are Roche Holding AG, Bayer AG, Novartis International AG, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Chengdu Kanghong Pharmaceutical Group Co. Ltd., Spark Therapeutics Inc., Genentech Inc., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Aerpio Pharmaceuticals Inc., REGENXBIO Inc., Stealth BioTherapeutics Corp., Adverum Biotechnologies Inc., Graybug Vision Inc., Oxurion NV, PanOptica Inc., Clearside Biomedical Inc.

North America was the largest region in the retinal vein occlusion treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal vein occlusion treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the retinal vein occlusion treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The retinal vein occlusion treatment market consists of revenues earned by entities by providing services such as laser therapy, medication administration, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The retinal vein occlusion treatment market also includes sales of vitrectomy equipment, and optical coherence tomography (OCT) devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Retinal Vein Occlusion Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on retinal vein occlusion treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for retinal vein occlusion treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The retinal vein occlusion treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Central Retinal Vein Occlusion (CRVO); Branch Retinal Vein Occlusion (BRVO)
• 2) By Diagnosis: Optical Coherence Tomography; Fundoscopic Examination; Fluorescein Angiography
• 3) By Treatment: Anti-Vascular Endothelial Growth Factor (Anti-VEGF); Corticosteroid Drugs; Other Treatments
• 4) By End-User: Hospital And Clinics; Research And Academics; Other End-Users
• Subsegments:
• 1) By Central Retinal Vein Occlusion (CRVO): Non-Ischemic CRVO; Ischemic CRVO
• 2) By Branch Retinal Vein Occlusion (BRVO): Non-Ischemic BRVO; Ischemic BRVO
• Companies Mentioned: Roche Holding AG; Bayer AG; Novartis International AG; Regeneron Pharmaceuticals Inc.; Bausch Health Companies Inc.; Santen Pharmaceutical Co. Ltd.; Chengdu Kanghong Pharmaceutical Group Co. Ltd.; Spark Therapeutics Inc.; Genentech Inc.; Apellis Pharmaceuticals Inc.; Alimera Sciences Inc.; Ocular Therapeutix Inc.; EyePoint Pharmaceuticals Inc.; Aerpio Pharmaceuticals Inc.; REGENXBIO Inc.; Stealth BioTherapeutics Corp.; Adverum Biotechnologies Inc.; Graybug Vision Inc.; Oxurion NV; PanOptica Inc.; Clearside Biomedical Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Retinal Vein Occlusion Treatment Market Characteristics

3. Retinal Vein Occlusion Treatment Market Trends And Strategies

4. Retinal Vein Occlusion Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Retinal Vein Occlusion Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Retinal Vein Occlusion Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Retinal Vein Occlusion Treatment Market Growth Rate Analysis
• 5.4. Global Retinal Vein Occlusion Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Retinal Vein Occlusion Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Retinal Vein Occlusion Treatment Total Addressable Market (TAM)

6. Retinal Vein Occlusion Treatment Market Segmentation

• 6.1. Global Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Central Retinal Vein Occlusion (CRVO)
• Branch Retinal Vein Occlusion (BRVO)
• 6.2. Global Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Optical Coherence Tomography
• Fundoscopic Examination
• Fluorescein Angiography
• 6.3. Global Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF)
• Corticosteroid Drugs
• Other Treatments
• 6.4. Global Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Clinics
• Research And Academics
• Other End-Users
• 6.5. Global Retinal Vein Occlusion Treatment Market, Sub-Segmentation Of Central Retinal Vein Occlusion (CRVO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Ischemic CRVO
• Ischemic CRVO
• 6.6. Global Retinal Vein Occlusion Treatment Market, Sub-Segmentation Of Branch Retinal Vein Occlusion (BRVO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Ischemic BRVO
• Ischemic BRVO

7. Retinal Vein Occlusion Treatment Market Regional And Country Analysis

• 7.1. Global Retinal Vein Occlusion Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Retinal Vein Occlusion Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Retinal Vein Occlusion Treatment Market

• 8.1. Asia-Pacific Retinal Vein Occlusion Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Retinal Vein Occlusion Treatment Market

• 9.1. China Retinal Vein Occlusion Treatment Market Overview
• 9.2. China Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Retinal Vein Occlusion Treatment Market

• 10.1. India Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Retinal Vein Occlusion Treatment Market

• 11.1. Japan Retinal Vein Occlusion Treatment Market Overview
• 11.2. Japan Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Retinal Vein Occlusion Treatment Market

• 12.1. Australia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Retinal Vein Occlusion Treatment Market

• 13.1. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Retinal Vein Occlusion Treatment Market

• 14.1. South Korea Retinal Vein Occlusion Treatment Market Overview
• 14.2. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Retinal Vein Occlusion Treatment Market

• 15.1. Western Europe Retinal Vein Occlusion Treatment Market Overview
• 15.2. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Retinal Vein Occlusion Treatment Market

• 16.1. UK Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Retinal Vein Occlusion Treatment Market

• 17.1. Germany Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Retinal Vein Occlusion Treatment Market

• 18.1. France Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Retinal Vein Occlusion Treatment Market

• 19.1. Italy Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Retinal Vein Occlusion Treatment Market

• 20.1. Spain Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Retinal Vein Occlusion Treatment Market

• 21.1. Eastern Europe Retinal Vein Occlusion Treatment Market Overview
• 21.2. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Retinal Vein Occlusion Treatment Market

• 22.1. Russia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Retinal Vein Occlusion Treatment Market

• 23.1. North America Retinal Vein Occlusion Treatment Market Overview
• 23.2. North America Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Retinal Vein Occlusion Treatment Market

• 24.1. USA Retinal Vein Occlusion Treatment Market Overview
• 24.2. USA Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Retinal Vein Occlusion Treatment Market

• 25.1. Canada Retinal Vein Occlusion Treatment Market Overview
• 25.2. Canada Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Retinal Vein Occlusion Treatment Market

• 26.1. South America Retinal Vein Occlusion Treatment Market Overview
• 26.2. South America Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Retinal Vein Occlusion Treatment Market

• 27.1. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Retinal Vein Occlusion Treatment Market

• 28.1. Middle East Retinal Vein Occlusion Treatment Market Overview
• 28.2. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Retinal Vein Occlusion Treatment Market

• 29.1. Africa Retinal Vein Occlusion Treatment Market Overview
• 29.2. Africa Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Retinal Vein Occlusion Treatment Market Competitive Landscape And Company Profiles

• 30.1. Retinal Vein Occlusion Treatment Market Competitive Landscape
• 30.2. Retinal Vein Occlusion Treatment Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Retinal Vein Occlusion Treatment Market Other Major And Innovative Companies

• 31.1. Santen Pharmaceutical Co. Ltd.
• 31.2. Chengdu Kanghong Pharmaceutical Group Co. Ltd.
• 31.3. Spark Therapeutics Inc.
• 31.4. Genentech Inc.
• 31.5. Apellis Pharmaceuticals Inc.
• 31.6. Alimera Sciences Inc.
• 31.7. Ocular Therapeutix Inc.
• 31.8. EyePoint Pharmaceuticals Inc.
• 31.9. Aerpio Pharmaceuticals Inc.
• 31.10. REGENXBIO Inc.
• 31.11. Stealth BioTherapeutics Corp.
• 31.12. Adverum Biotechnologies Inc.
• 31.13. Graybug Vision Inc.
• 31.14. Oxurion NV
• 31.15. PanOptica Inc.

32. Global Retinal Vein Occlusion Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Retinal Vein Occlusion Treatment Market

34. Recent Developments In The Retinal Vein Occlusion Treatment Market

35. Retinal Vein Occlusion Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Retinal Vein Occlusion Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Retinal Vein Occlusion Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Retinal Vein Occlusion Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer